v3.23.3
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Federal grants $ 435,380 $ 279,351 $ 1,715,488 $ 1,089,920
Operating expenses:        
Research and development 1,914,970 4,756,096 5,354,713 13,393,948
General and administrative 1,227,724 1,686,580 3,923,277 5,717,281
Total operating expenses 3,142,694 6,442,676 9,277,990 19,111,229
Loss from operations (2,707,314) (6,163,325) (7,562,502) (18,021,309)
Other income (expense):        
Issuance costs for convertible notes (1,118,721) (1,118,721)
Loss on issuance of convertible notes (3,609,944) (3,609,944)
Change in fair value of convertible notes 3,491,513 146,479 6,169,929
Issuance of liability classified warrants (3,737,371) (3,737,371)
Change in fair value of liability classified warrants 17,223 2,683,340 279,873 5,626,130
Loss on debt conversions (1,404,877) (4,000,155)
Interest expense, net (7,649) (4,859) (9,146) (57,662)
Other income, net 6,934 8,679 23,382 19,494
Total other income (expense), net 16,508 (3,692,240) 440,588 (708,300)
Net loss (2,690,806) (9,855,565) (7,121,914) (18,729,609)
Net loss attributable to noncontrolling interests (1,235) (21,492) (12,236) (47,619)
Deemed dividend related to warrants down round provision 63,539 12,038 881,598
Net loss attributable to common stockholders $ (2,689,571) $ (9,897,612) $ (7,121,716) $ (19,563,588)
Net loss per basic and diluted share:        
Net loss per share attributable to common stockholders, basic $ (0.87) $ (61.58) $ (3.32) $ (140.90)
Net loss per share attributable to common stockholders, diluted $ (0.87) $ (61.58) $ (3.32) $ (140.90)
Weighted average common shares outstanding, basic 3,085,873 160,719 2,145,505 138,849
Weighted average common shares outstanding, diluted 3,085,873 160,719 2,145,505 138,849

Source